Article info
Original research
Regulation of the KATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain
- Correspondence to Dr Wen-Tao Liu, Pharmacology, Nanjing Medical University, Nanjing, China; painresearch{at}njmu.edu.cn; Dr Hang Xiao; hxiao{at}njmu.edu.cn; Professor Ji-Hua Liu; liujihua{at}cpu.edu.cn
Citation
Regulation of the KATP-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain
Publication history
- Received February 21, 2020
- Revision received July 29, 2020
- Accepted August 3, 2020
- First published September 22, 2020.
Article Versions
- You are currently viewing a Previous version of this article (23 November 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Society of Regional Anesthesia & Pain Medicine 2020. No commercial re-use. See rights and permissions. Published by BMJ.